ISSUE 82 I MAY 2019

Where is

 my mind?

 An experimental drug is fuelling hopes that a treatment for memory loss may be on the horizon

Cannabis in the UK 

The potential of ketamine 

RUNLABS: flexible working environments 

In association  with

06/07/2019 06:09:15
  • Home | Where is my mind?
  • In this issue
  • Scandinavian Health Company Insight
  • Scandinavian Health
  • Contents
  • NSF
  • News
  • Daiichi Jitsugyo
  • The pharma industry briefing
  • International Cannabis and Cannabinoid Institute (ICCI) Company Insight
  • International Cannabis and Cannabinoid Institute (ICCI)
  • Thumbs up for esketamine sheds light on potential for ketamine
  • Phoenix group Company Insight
  • Phoenix group
  • Charting the life and times of the EMA as it leaves London
  • Swiss WorldCargo
  • Capsugel Company Insight
  • Capsugel
  • Medical cannabis in the UK: how has the roll out gone so far?
  • EmboCaps
  • Barc Lab
  • Drug development: the researchers driving an open-science approach
  • Freudenberg Medical
  • Albypharma
  • The drugs fighting memory loss
  • Senn Chemicals
  • Pharma Hemp
  • RUNLABS: empowering life science through flexible working environments
  • Spirax Sarco
  • Spirax Sarco Company Insight
  • Events
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • B&W Tek
  • Next issue
  • Pfanstiehl
  • Centaur Clinical | Company Insight
  • Centaur Clinical
  • Hapa Company Insight
  • Contract Pharmaceuticals Limited Canada